Efficacy of radiofrequency ablation combined with sorafenib for treating liver cancer complicated with portal hypertension and prognostic factors

Table 7 Logistic multivariate regression analysis of poor prognosis in patients with liver cancer complicated with portal hypertension

Item	β	SE	Wald	P value	Exp (B)	95%CI
High Child-Pugh grade	1.470	0.738	3.970	0.046	4.349	1.024-18.469
History of hepatitis	2.286	0.803	8.098	0.004	9.833	2.037-47.463
Tumor size (6-10 cm)	2.399	0.788	9.268	0.002	11.008	2.350-51.567
No use of sorafenib	2.483	0.829	8.963	0.003	11.981	2.357-60.884
Liver cancer of stage IIIC	1.900	0.719	6.988	0.008	6.683	1.634-27.329
Previous splenectomy	1.629	0.741	4.835	0.028	5.101	1.194-21.800
Constant	6.685	1.486	20.226	< 0.001	0.001